Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative effect of lorazepam versus midazolam for sedation in mechanically ventilated ICU patients
IRCT20220424054631N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lorazepam and midazolam in sedation (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Sedation effectiveness. Started Apr 2022; status: completed.
02
Drugs
lorazepammidazolam
03
Conditions
sedation
Beyond the preview
Go deeper on IRCT20220424054631N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220424054631N1.